Article Versions Notes

Drolet B, Pilote S, Gélinas C, Kamaliza A-D, Blais-Boilard A, Virgili J, Patoine D, Simard C. Altered Protein Expression of Cardiac CYP2J and Hepatic CYP2C, CYP4A, and CYP4F in a Mouse Model of Type II Diabetes—A Link in the Onset and Development of Cardiovascular Disease? Pharmaceutics. 2017; 9(4):44. https://doi.org/10.3390/pharmaceutics9040044

Drolet, Benoit, Sylvie Pilote, Carolanne Gélinas, Alida-Douce Kamaliza, Audrey Blais-Boilard, Jessica Virgili, Dany Patoine, and Chantale Simard. 2017. "Altered Protein Expression of Cardiac CYP2J and Hepatic CYP2C, CYP4A, and CYP4F in a Mouse Model of Type II Diabetes—A Link in the Onset and Development of Cardiovascular Disease?" Pharmaceutics 9, no. 4: 44. https://doi.org/10.3390/pharmaceutics9040044

Drolet, B., Pilote, S., Gélinas, C., Kamaliza, A. -D., Blais-Boilard, A., Virgili, J., Patoine, D., & Simard, C. (2017). Altered Protein Expression of Cardiac CYP2J and Hepatic CYP2C, CYP4A, and CYP4F in a Mouse Model of Type II Diabetes—A Link in the Onset and Development of Cardiovascular Disease? Pharmaceutics, 9(4), 44. https://doi.org/10.3390/pharmaceutics9040044